These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 15849820)
1. Construction and characterization of chimeric BHIV (BIV/HIV-1) viruses carrying the bovine immunodeficiency virus gag gene. Zhu YX; Liu C; Liu XL; Qiao WT; Chen QM; Zeng Y; Geng YQ World J Gastroenterol; 2005 May; 11(17):2609-15. PubMed ID: 15849820 [TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of a chimeric virus (BIV/HIV-1) carrying the bovine immunodeficiency virus gag-pol gene. Chen G; Wang S; Xiong K; Wang J; Ye T; Dong W; Wang Q; Chen Q; Geng Y; Wood C; Zeng Y AIDS; 2002 Jan; 16(1):123-5. PubMed ID: 11741171 [TBL] [Abstract][Full Text] [Related]
3. [Construction and analysis of activity of an HIV-1/bovine immunodeficiency virus chimeric clone cDNA]. Yang YS; Chen GM; Dong WP; Chen QM; Geng YQ; Zeng Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):143-5. PubMed ID: 12869996 [TBL] [Abstract][Full Text] [Related]
4. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1. Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884 [TBL] [Abstract][Full Text] [Related]
5. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus. Rasmussen L; Battles JK; Ennis WH; Nagashima K; Gonda MA Virology; 1990 Oct; 178(2):435-51. PubMed ID: 1699349 [TBL] [Abstract][Full Text] [Related]
6. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
7. Immunological characterization of the gag gene products of bovine immunodeficiency virus. Battles JK; Hu MY; Rasmussen L; Tobin GJ; Gonda MA J Virol; 1992 Dec; 66(12):6868-77. PubMed ID: 1331499 [TBL] [Abstract][Full Text] [Related]
8. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. Porter DC; Ansardi DC; Choi WS; Morrow CD J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902 [TBL] [Abstract][Full Text] [Related]
10. Construction of gag-chimeric viruses between HIV-1 and SIVmac that are capable of productive multi-cycle infection. Kamada K; Yoshida A; Khamsri B; Piroozmand A; Yamashita T; Uchiyama T; Fujita M; Adachi A Microbes Infect; 2006 Apr; 8(4):1075-81. PubMed ID: 16520079 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles. Park J; Morrow CD Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189 [TBL] [Abstract][Full Text] [Related]
13. Animal models for HIV infection and AIDS: memorandum from a WHO meeting. Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118 [TBL] [Abstract][Full Text] [Related]
14. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retroviruses. Sherman MP; Dock NL; Ehrlich GD; Sninsky JJ; Brothers C; Gillsdorf J; Bryz-Gornia V; Poiesz BJ AIDS Res Hum Retroviruses; 1995 Mar; 11(3):409-14. PubMed ID: 7786586 [TBL] [Abstract][Full Text] [Related]
16. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236 [TBL] [Abstract][Full Text] [Related]
17. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Haglund K; Forman J; Kräusslich HG; Rose JK Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333 [TBL] [Abstract][Full Text] [Related]
18. Each genomic RNA in HIV-1 heterozygous virus generate new virions. Iglesias-Sanchez MJ; Lopez-Galindez C Virology; 2005 Mar; 333(2):316-23. PubMed ID: 15801124 [TBL] [Abstract][Full Text] [Related]
19. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. Sova P; Volsky DJ; Wang L; Chao W J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958 [TBL] [Abstract][Full Text] [Related]
20. Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice. Wong SB; Siliciano RF J Virol; 2005 Feb; 79(3):1701-12. PubMed ID: 15650195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]